ArticleInternational journal of molecular sciences2023

Immune Checkpoint Inhibitor, Nivolumab, Combined with Chemotherapy Improved the Survival of Unresectable Advanced and Metastatic Esophageal Squamous Cell Carcinoma: A Real-World Experience.

Ming-Wei Kao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.